Efficacy of Lactobacillus Rhamnosus GG on preventing acute phases in patients affected by allergic conjunctivitis - ND

Active, not recruiting

• Conditions: allergic conjunctivitis; MedDRA version: 9.1Level: LLTClassification code 10010744Term: Conjunctivitis allergic

• Registration Number: EUCTR2007-000209-31-IT
• Lead Sponsor: IVERSITA CAMPUS BIOMEDICO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-04-12
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

age 5-16 years; diagnosys of allergic conjunctivitis in non active phase; signed informed consent; ability to follow all the instructions; ability to follow visit schedule
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

concomitant ocular pathologies; use of contact lenses; cardiovascular disease.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Reduction of frequency of acute phases;Secondary Objective: Modification in clinical signs and simptoms; Biochemical and molecular markers of inflamation;Primary end point(s): number of acute phases